AROMASIN is indicated for adjuvant procedure of postmenopausal Women of all ages with estrogen-receptor optimistic early breast cancer who have obtained two to 3 many years of tamoxifen and are switched to AROMASIN for completion of a complete of five consecutive years of adjuvant hormonal therapy [see Scientific Experiments (fourteen.one)].larotre